The DEAH-box family of RNA-dependent NTPases (DHX) plays a crucial role in RNA metabolism, including processes such as splicing, ribosome biogenesis, and mRNA export from the nucleus. These proteins act as molecular motors that harness the energy from nucleotide hydrolysis to unwind or remodel RNA and RNA-protein complexes. The DHX proteins generally contain conserved motifs that are essential for ATP binding and hydrolysis, as well as RNA binding and unwinding. Through their ATPase and helicase activities, DHX proteins are able to dynamically regulate the structure and function of various RNA molecules and complexes, thereby influencing diverse cellular processes.
The class of molecules known as DEAH-box RNA-dependent NTPase (DHX) Inhibitors is specifically designed to modulate the activity of the DHX family of proteins, which are central to RNA metabolism in the cell. These inhibitors typically target the ATPase or helicase domains of DHX proteins, as these are the functional cores responsible for nucleotide binding, hydrolysis, and the subsequent RNA remodeling activities. Some inhibitors may act by binding directly to the ATPase pocket, thereby ATP from binding and disabling the enzyme's activity. Others may bind to regions of the protein that are essential for RNA interaction, therefore making the protein unable to engage with its natural RNA substrates. Some inhibitors are allosteric in nature and can bind to regions other than the active site, causing conformational changes that make the enzyme less effective or completely inactive.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor affecting downstream RNA processing pathways. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, indirectly affecting RNA processing. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits JNK, which plays a role in RNA splicing. | ||||||
Akt Inhibitor IV | 681281-88-9 | sc-203809 sc-203809A | 5 mg 25 mg | $176.00 $709.00 | 42 | |
Inhibits Akt, which is involved in RNA processing. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can affect RNA splicing. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Influences function of RNA helicases like DDX38 by causing DNA damage. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Interferes with RNA helicase activity indirectly by disrupting nucleotide metabolism. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Topoisomerase II inhibitor potentially affecting RNA processing. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Interferes with DNA synthesis and repair, affecting RNA helicases like DDX38. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Topoisomerase I inhibitor that causes DNA damage affecting RNA helicases like DDX38. | ||||||